文献速递心律失常

Apple Watch 在卒中高危人群中提高房颤检出率:随机对照试验

Enhanced Detection and Prompt Diagnosis of Atrial Fibrillation Using Apple Watch: A Randomized Controlled Trial.
PubMed 文献 · J Am Coll Cardiol · 2026-01-22

本研究为前瞻性多中心随机对照试验,纳入荷兰2个二级医疗中心437例≥65岁且卒中风险升高的患者,比较Apple Watch远程筛查与标准管理对新发房颤的检出效果。结果显示,智能手表组新发房颤检出率为9.6%,显著高于对照组的2.3%,风险差为7.3个百分点。该6个月基于光电容积描记和单导联心电图的远程筛查可提高卒中高危人群的新发房颤检出。

要点

  • Apple Watch监测6个月使新发房颤检出率较标准管理提高4.4倍。
  • 适用于CHA2DS2-VASc≥2分男性或≥3分女性的≥65岁患者。
  • 远程eHealth团队需在24小时内审核单导联心电图结果。

核心结论

  • 6个月Apple Watch筛查可较标准管理显著提高卒中风险升高患者的新发房颤检出率。

研究设计与样本

  • 纳入437例≥65岁、CHA2DS2-VASc≥2分男性或≥3分女性的卒中风险升高患者,随机分为干预组219例和对照组218例。
  • 干预组接受180天Apple Watch监测,具备光电容积描记和单导联心电图功能,心电图由独立eHealth团队24小时内远程审核。
  • 中位年龄75岁,46.7%为女性,中位CHA2DS2-VASc评分为3.0。

主要发现

  • 干预组新发房颤21例(9.6%),对照组5例(2.3%),风险差7.3个百分点(95% CI:2.9-11.7个百分点;P=0.001;HR:4.40;95% CI:1.66-11.66)。
  • 仅在干预组中检出若干无症状房颤发作,两组均检出阵发性房颤。

关键数值与推荐

  • 新发房颤定义为单导联心电图或标准心电图方法确认的持续≥30秒的发作。
  • 患者纳入标准:年龄≥65岁,男性CHA2DS2-VASc≥2分或女性≥3分。

临床怎么用

  • 对卒中风险升高的≥65岁患者可考虑使用Apple Watch进行6个月房颤筛查。
  • 筛查需配合远程eHealth团队对心电图进行24小时内审核以确认诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Atrial fibrillation (AF), the most common cardiac arrhythmia, is a major cause of stroke and often remains undiagnosed due to its paroxysmal and frequently asymptomatic nature. Wearables provide a scalable, noninvasive screening tool. OBJECTIVES: This trial evaluated new onset AF detection in patients at elevated stroke risk using remote smartwatch-based screening. METHODS: This prospective multicenter randomized controlled trial included patients ≥65 years with elevated stroke risk (CHA2DS2-VASc ≥2 men, ≥3 women) from 2 secondary care centers in the Netherlands. Patients were randomized to 6-month (180-day) monitoring with a smartwatch with photoplethysmography and single-lead electrocardiogram (ECG) functions, or standard care. ECGs were reviewed remotely by an independent eHealth team within 24 hours. The primary outcome was new onset AF, defined as a confirmed episode lasting ≥30 seconds on single-lead ECG or standard ECG methods. RESULTS: Between November 2022 and December 2023, 437 patients were randomized (219 intervention, 218 control); the median age was 75 years, 46.7% were female and the median CHA2DS2-VASc score was 3.0. New onset AF occurred in 21 (9.6%) patients of the intervention group and 5 (2.3%) patients of the control group (risk difference: 7.3 percentage points; 95% CI: 2.9-11.7 percentage points; P = 0.001; HR: 4.40; 95% CI: 1.66-11.66). Several asymptomatic AF episodes were detected only in the intervention group, while paroxysmal AF occurred in both groups. CONCLUSIONS: This randomized controlled trial provides evidence that 6-month smartwatch-based AF screening enhances the detection rate of new onset AF compared with standard care in patients at elevated stroke risk. (Detection and Quantification of Atrial Fibrillation in High-risk Patients Using a Smartwatch Wearable [Apple Watch] [EQUAL]; NCT05686330).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. van Steijn, Blommestijn, Blok, et al. Enhanced Detection and Prompt Diagnosis of Atrial Fibrillation Using Apple Watch: A Randomized Controlled Trial. J Am Coll Cardiol. 2026. PMID: 41569211. doi:10.1016/j.jacc.2025.11.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。